EMEA-001454-PIP05-18 - paediatric investigation plan
binimetinib
PIPHuman
Pierre Fabre Médicament
Tel. +33 800326326
E-mail: medical_information@pierre-fabre.com
P/0037/2019: EMA decision of 29 January 2019 on the granting of a product specific waiver for binimetinib (Mektovi), (EMEA-001454-PIP05-18)